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In mammalian mitochondria the translational machinery is of
dual originwith tRNAs encodedby a simplified and rapidly evolving
mitochondrial (mt) genome and aminoacyl-tRNA synthetases
(aaRS) coded by the nuclear genome, and imported. Mt-tRNAs are
atypical with biased sequences, size variations in loops and stems,
and absence of residues forming classical tertiary interactions,
whereas synthetases appear typical. This raises questions about
identity elements in mt-tRNAs and adaptation of their cognate mt-
aaRSs. We have explored here the human mt-aspartate system in
which a prokaryotic-type AspRS, highly similar to the Escherichia
coli enzyme, recognizes a bizarre tRNAAsp. Analysis of human mt-
tRNAAsp transcripts confirms the identity role of the GUC anti-
codon as in other aspartylation systems but reveals the non-involve-
ment of position 73. This position is otherwise known as the site of
a universally conserved major aspartate identity element, G73, also
known as a primordial identity signal. In mt-tRNAAsp, position 73
can be occupied by any of the four nucleotides without affecting
aspartylation. Sequence alignments of variousAspRSs allowedplac-
ing Gly-269 at a position occupied by Asp-220, the residue contact-
ing G73 in the crystallographic structure of E. coli AspRS-tRNAAsp
complex. Replacing this glycine by an aspartate renders humanmt-
AspRSmore discriminative to G73. Restriction in the aspartylation
identity set, driven by a rapid mutagenic rate of the mt-genome,
suggests a reverse evolution of themt-tRNAAsp identity elements in
regard to its bacterial ancestor.
Specific aminoacylation of transfer RNAs (tRNA) by their cognate
aminoacyl-tRNA synthetases (aaRS)4 is a key step in translation of
genetic information. Rules governing recognition between partnermac-
romolecules have been well studied for a large number of prokaryotic
and cytosolic eukaryotic systems (1–3). They rely on identity nucleo-
tides, mainly located at both extremities of the tRNA L-shape, that
contact specific amino acids in the aaRS structure. Composed of major
and minor elements, identity sets are usually conserved during evolu-
tion, as is the architecture of tRNA (1, 3). However, they can be com-
pleted by idiosyncratic subtleties such as cryptic (4) or permissive (5)
elements and structural features including flexibility and the overall
tRNA scaffold (6, 7). Despite that, identity sets remainmainly unknown
for organellar tRNAs, in particular for mammalian mitochondrial (mt)-
tRNAs, a group of atypical macromolecules.
Mammalian mt-tRNAs differ from classical tRNAs at the structural
level and in regard to potential identity sets (8). Coded by the mt
genome, they display non-canonical features and significantly degener-
ated sequences (8, 9). A majority (14 of 22) possess a biased nucleotide
composition, unusual sizes of D- and/or T-loops, and miss otherwise
conserved residues required for three-dimensional folding. Identity ele-
ments are only sparsely known. According to the endosymbiotic
hypothesis on the origin of mitochondria (10) and the ability of mt-
aaRSs to aminoacylate Escherichia coli tRNAs (11), identity elements of
E. coli tRNAs were searched in the corresponding mammalian
mt-tRNA sequences, and some have indeed been found (8). Conversely
for the large sequence and structural degeneracy of mammalian mt-
tRNAs, corresponding mt-aaRSs seem not to depart from the already
known synthetases (Refs. 12, 13 and references therein). They are
nuclear encoded and possess anmt-targeting signal. Recent completion
of the full set of human (Hs) mt-aaRS genes confirms the view that,
except for GlyRS5 and LysRS, mt and cytosolic aaRSs are coded by two
different sets of genes (12). The human synthetases of mt location have
no apparent structural peculiarities compared with related synthetases
(except PheRS, which is a monomer instead of an 22 tetramer). They
belong to the expected aaRS classes because they possess either of the
two signatures in the catalytic domain (Rossmann-fold for class I; semi-
conserved motifs 1, 2, and 3 for class II) (14, 15). In a larger frame,
mt-aaRSs from various organisms present, with a few exceptions, typi-
cal and expected features of synthetases (13, 16, 17).
Apposition of “bizarre” tRNAs versus standard aaRSs raises a ques-
tion as to the rules governing recognition and specific aminoacylation.
To shed light on this question, we have explored theHsmt aspartylation
system. This choice is guided by the extensive knowledge of aspartyla-
tion identity elements in various organisms including E. coli (18, 19),
Saccharomyces cerevisiae (20–23), and Thermus thermophilus (24).
Further, Hs mt-AspRS was recently cloned and overexpressed and is
one of the few mt synthetases with enough solubility to be analyzed
biochemically (12).
Hs mt-tRNAAsp presents characteristic mammalian mt-tRNA fea-
tures. When compared with “classical” tRNAs (Fig. 1, A and B), it has
shorter D- and T-loops and a biased nucleotide composition with 29 A,
7 G, 24 U, 11 C leading to a high content of weak base pairs (16 A-U and
G-Upairs versus only 5G-Cpairs). Typical signals important for tertiary
interactions are missing, such as residues G18 and G19 in the D-loop
and the UUC sequence (the precursor of TC) in the T-loop involved
in long-range interactions. Altogether, only 5 of the 9 expected tertiary
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interactions involved in an L-shaped three-dimensional folding (25)
could be predicted. These structural features suggest a muchmore flex-
ible structure for mt-tRNAAsp than for classical tRNAs (8).
Sequence comparison of classical (i.e. non-mt) tRNAAsp molecules
highlighted conserved nucleotides that have proven to be major aspar-
tate identity elements in all systems tested so far (reviewed in Refs. 26,
27). They correspond to the discriminator residue G73 and the antic-
odon triplet G34-U35-C36. Aspartate identity is further defined by
additional elements ofminor strength such as residue C38 and base pair
G10-U/C25, and further in E. coli by the species-specific G2-C71 pair
(Fig. 1A). Surprisingly, Hs mt-tRNAAsp presents the potential major
elements within the anticodon triplet, but not the discriminator base
G73. Further, within theminor elements, only the pair G10-C25 is pres-
ent whereas C38, as well as the minor E. coli signal G2-C71, is missing.
Analysis of the consensus of 136 mammalian mt-tRNAAsp sequences
(Fig. 1C) confirms a strong conservation (albeit not total) of the antic-
odon triplet nucleotides and the absence of nucleotide conservation at
position 73 and of the minor elements. It highlights base pairs R2-U71
(R for purine) and A49-U65 as strongly conserved, designating them as
potential identity elements. This analysis leads to the hypothesis that Hs
mt-tRNAAsp presents either a reduced or an alternate identity set com-
pared with the so far known other aspartate tRNAs.
In contrast, cognate nuclear-encodedHsmt-AspRS, recently charac-
terized (12), displays standard features and resembles known AspRSs.
Markedly, it is a class II synthetase, has the typical bacterial insertion
andC-terminal extension, and shares40% of strictly identical residues
with E. coli AspRS.
We have shown here that Hs mt-tRNAAsp conserves GUC aspartate
anticodon as identity elements but not the discriminator position 73.
This indicates simplified aspartate identity rules in the Hs mt system.
Sequence comparison shows a local structural deviation in the mt
enzyme next to the discriminator position in the tRNA. Accordingly, an
mt-AspRS could be engineered to partially restore its discriminating
capacity for G73. This is in favor of a local and focused adaptation of the
slowly evolving nuclear-encoded enzyme, allowing for the unimpor-
tance of residue 73 rather than for recognition of an alternative nucle-
otide at this position. These data will be discussed in light of molecular
evolution of tRNA aminoacylation systems in the peculiar mt context.
EXPERIMENTAL PROCEDURES
Materials—Synthetic genes of yeast (28), E. coli (20), and Hs mt-
tRNAAsp (12) were previously cloned. The T. thermophilus tRNAAsp
transcript and E. coliAspRS were gifts fromH. Becker and G. Eriani. Hs
mt-tRNATyr transcripts were gifts from L. Bonnefond and J. Rudinger-
Thirion. Hs mt-AspRS was cloned (plasmid pQE70-mt-AspRS), over-
expressed, and purified as described (12). T7 RNApolymerase was puri-
fied as described (24). Oligonucleotides were from Sigma Genosys,
restriction enzymes (BamHI, HindIII, and BstNI) from New England
Biolabs, T4 DNA ligase from Qbiogen, and L-[3H]aspartic acid (1.37
TBq/mmol) from Amersham Biosciences.
tRNA Gene Mutagenesis and in Vitro Transcription—Hs mt-tRNAAsp
variant geneswere obtained by hybridization of 9 overlapping oligonucleo-
tides, ligation between BamHI and HindIII sites of plasmid pTFMa (28),
and transformation into TG1 cells. Mutant genes were obtained with the
QuikChangeTM site-directed mutagenesis kit (Stratagene). These genes
contain a hammerhead ribozyme (29) and tRNA sequences downstream
the T7 polymerase promoter. A BstNI site coincidental with the 3-end of
the tRNA sequences allows synthesis of tRNAs ending with the expected
CCA sequence. Transcription was as described (29).
mt-AspRS Mutagenesis and Expression—Plasmid pQE70-mt-AspRS
was converted into pQE70-mt-AspRS/G269D using the QuikChangeTM
site-directed mutagenesis kit (Stratagene) and transformation of E. coli
TOP10 strain. Mt-AspRS/G269D was expressed and purified on nickel
affinity column (12). Protein concentration was determined from A280
using an extinction coefficient calculated with ProtParam from Expasy
tools ( 43540M1cm1).
Aminoacylation—Assays were performed as described (12) except
that they were conducted at 15 instead of 25 °C. Buffer conditions were
50 mM HEPES-KOH, pH 7.5, 25 mM KCl, 12 mM MgCl2, 2.5 mM ATP,
0.2mg/ml of bovine serumalbumin, 1mM spermine, 32M [3H]aspartic
acid (208 GBq/mmol), and adequate amounts of transcripts and aaRS.
Assays were performed in 50-l samples. Transcripts were renatured
(60 °C for 90 s in water and slow cooling down to room temperature)
before aminoacylation was performed at 15 °C.Maximal charging levels
(plateaus) were determined for 400 nM transcript and 680 nM synthetase
(wild-type (WT) or G269D mutant AspRS). Under such conditions,
plateaus determine the percentage of active molecules in each tRNA
preparation (30). Plateau values varying between 40 and 80% were
obtained and taken into account forKm calculations. Synthetase activity
wasmeasured under excess substrate (8M) and 50 nM enzyme. Kinetic
FIGURE 1. Human mt-tRNAAsp is structurally bizarre and misses some classical
aspartate identity elements. A, cloverleaf representation of a canonical tRNA with
strictly conserved residues and tertiary interactions (dotted lines) emphasized. Y and R
stand for pyrimidine and purine, respectively. Major (thick circles) andminor (thin circles)
aspartate identity elements in yeast, T. thermophilus, and E. coli (26) are shown. The E. coli
minor element is in dotted circles. Numbering is according to Ref. 41. B, cloverleaf repre-
sentation of Hs mt-tRNAAsp (59) with tentative tertiary interactions (dotted lines). Notice
the particular D- and T-loops. Expected identity elements are circled, and missing ele-
ments pinpointed by arrows. C, consensus sequence of mt-tRNAAsp genes from 136
mammals. The non-encoded CCA end is omitted.
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parameters kcat and Km were derived from Lineweaver-Burk plots
obtained under adequate ranges of tRNA (40 nM-1 M) and AspRS
(50–200 nM). For tRNAAsp mutant C36U, kcat/Km was determined
according to Ref. 31. Experiments were at least tripled on separate prep-
arations of transcripts. Values varied up to 40%.
RESULTS ANDDISCUSSION
Preliminary Considerations—Aspartate identity elements have been
searched for by evaluation of the aspartylation properties of in vitro
transcribed Hs mt-tRNAs. This strategy is of particular interest for
humanmt-tRNAs because it allows preparation of sufficient amounts of
RNA either of WT or mutated sequence and has already been success-
fully applied for several human mt-tRNAs despite a number of draw-
backs (reviewed in Ref. 32). Post-transcriptional modifications, absent
in transcripts, may stabilize tRNA structure and/or provide a recogni-
tion element for interacting partners such as aaRSs. However, in the
case of Hs mt-tRNAAsp we believe that the absence of such modifica-
tions does not significantly affect aminoacylation properties. Compar-
ative structure probing of native tRNA (extracted in nano-quantities
from HeLa cells) and transcripts leads to similar results (see below and
supplemental data). Further, post-transcriptional modifications have
never been reported so far as a positive aspartate determinant (for
instance, the yeastWT tRNAAsp transcript is only 10-fold less efficiently
aspartylated than native tRNA) (33), and this conclusion likely holds
true in the Hs mt system. Indeed, Hs WT-tRNAAsp transcript is aspar-
tylated with only a 11.5-fold lower efficiency than native E. coli tRNAAsp
(12).
However, as reported in several instances, handling of Hs mt-tRNAs
remains tricky, especially those tRNAs with a high A, U, and C content
(“light tRNAs”) that are thermodynamically weak (as is the case for
tRNAAsp) (9). Thus, aminoacylation assays have to be performed at low
temperatures, a compromise for optimal enzymatic activity and tRNA
stability (34, 35). In the present study, aminoacylation assays were per-
formed at 15 °C to allow for reproducible results. Lowering assay tem-
perature from 25 to 15 °C reduces the catalytic efficiency for aspartyla-
tion only 3-fold (kcat/Km of 77 103 s1M1 at 25 °C (Ref. 12) and
27 103 s1M1 at 15 °C; see Table 1). These efficiencies remain in a
range similar to those observed for other Hsmt aminoacylation systems
(12, 34–40).
TheAspartate Identity Set Is Simplified inHumanMitochondria—Iden-
tity elements for aspartylationwere searched by amutational analysis. A
first series of variants included single point mutations at nucleotide
positions that correspond to major aspartate identity determinants in
yeast, E. coli, andT. thermophilus, i.e. positions 34, 35, 36, and 73.Muta-
tions at positions 35 and 36 strongly impair aminoacylation (Fig. 2A)
and lead at least to a loss of catalytic efficiency (kcat/Km) of 215-fold
FIGURE 2. Aspartylation of human mt-tRNAAsp
variants with human mt-AspRS. Mutagenic
analysis on variants at N34, 35, or 36 (A), discrimi-
nator N73 (B), and anticodon loop N38 (C). Inserts
recall localization of the tested positions in the
tRNA. D, variants with changes in the two con-
served base pairs in mammalian mt-tRNAAsp
(squared positions on the schematized cloverleaf). E,
structural variants of tRNAAsp with D- and T-loops
from S. pombe tRNAAsp (see neighboring cloverleaf
for loop sequences). Aminoacylation assays were
performedasdescribedunder “Experimental Proce-
dures” with 8M transcripts and 50 nMAspRS.
TABLE 1
Kinetic parameters for tRNA aminoacylation by humanmt-AspRS
andmt-AspRS/G269D
In vitro aminoacylation assays have been performed at 15 °C under experimental
conditions as described under “Experimental Procedures.” ND, not determined.
TRNA kcat Km kcat/Km Loss
103 s1 M 103 s1M1
Wtmt-AspRS
wt tRNAAsp 5.3 1.7 0.19 0.08 27.9 1.0
G73 3.4 1.1 0.36 0.15 9.4 2.9
C73 3.0 1.0 0.09 0.04 33.3 0.8
U73 2.4 0.1 0.11 0.02 21.8 1.2
A34 5.3 1.3 2.18 0.47 2.4 11.5
C34 24.8 8.2 20.52 8.52 1.2 23.2
U34 12.3 4.3 6.09 2.40 2.0 13.9
A35 ND ND ND ND
C35 ND ND ND ND
G35 ND ND ND ND
A36 ND ND ND ND
G36 ND ND ND ND
U36 ND ND 0.13 215
Mutant mt-AspRS/G269D
wt tRNAAsp 0.6 0.1 0.10 0.07 6.0 1.0
G73 1.9 0.1 0.26 0.07 7.7 0.8
C73 0.6 0.2 0.08 0.07 7.5 0.8
U73 0.7 0.2 0.23 0.11 3.0 2.0
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(Table 1). Mutations at position 34 moderately decrease aspartylation
(Fig. 2A) with a loss in efficiency of 10- to 20-fold. In regard to the
discriminator position 73, replacement of A73 by G73, C73, or U73
keeps significant aspartylation activities with rates close to those ofWT
(Fig. 2B) and kinetic parameters for the three variants very similar to
those of WT (Table 1). Thus, although the anticodon nucleotides con-
tribute to identity, position 73 is no longer an identity element in the
human mitochondrial system.
Next, the contribution of nucleotides known asminor aspartate iden-
tity elements in bacterial or eukaryal systems was investigated. Replace-
ment of A38 by G38 decreases aminoacylation whereas replacement by
C38 or U38 increases it (Fig. 2C ). This surprising stimulation (not
observed for other aspartate tRNAs) could reveal either insertion of a
positive identity element, suggesting that natural mt-tRNA sequence
with A38 is not optimal for its cognate synthetase, or that a pyrimidine
at position 38 leads to structural rearrangements within the anticodon
domain favoring synthetase recognition. This hypothesis was tested by
comparing solution structures of both WT mt-tRNAAsp and variant
C38. The two transcripts share essentially similar reactivities against
enzymatic probes, indicative of a common global secondary structure.
They differ, however, from native mt-tRNAAsp at their D-domains
(detailed data to be published elsewhere). Reactivity of nucleotides
within the anticodon loop of the variants (supplemental Fig. S1) differs
at subtle levels, those of variant C38 being midway between those in the
post-transcriptionally modified native tRNA and those in the “naked”
WT transcript. This suggests that the increased aminoacylation capac-
ity of variant C38 is in part linked to a structural rearrangement of its
anticodon loop. C38 may mimic the structural role of post-transcrip-
tional modifications present in native tRNA.
Because of the importance of the anticodon loop inmt-tRNAAsp ami-
noacylation, the contribution of position 37 to aspartylation was also
tested, but none of the nucleotides introduced in place of A37 had an
effect (results not shown). Thus, A37 is not an identity element.
Base pair G2-C71 is a minor identity element in E. coli tRNAAsp (19).
In Hs mt-tRNAAsp, as in all other mammalian mt-tRNAAsp, the
sequence is conserved as R2-U71 (Fig. 1C), suggesting that it could be an
important signal for mt-AspRS. Another strictly conserved signal is
A49-U65 in the T-stem. Both base pairs were individually replaced by
G-C or U-A (Fig. 2D). Aminoacylation properties of the four new vari-
ants are close to those of WT transcript, showing that corresponding
WT nucleotides have no major contribution to mt aspartate identity.
An intriguing characteristic of mammalian mt-tRNAs is their unusual
D- and T-loop ensembles with no classical size or obvious signals for terti-
ary interactions. The importance of these typical structural features was
thus tested on aspartylation. Both loops of Hs mt-tRNAAsp were replaced
at once by those of Schizosaccharomyces pombe cytosolic tRNAAsp (Fig.
2E), where classical tertiary interactions can take place. Aspartylation of
this variant is not affected (Fig. 2E).
In summary, aspartylation of Hsmt-tRNAAsp is restricted to the anti-
codon residues (U35 and C36 as strongest elements, G34 as moderate
contributor). The discriminator residue 73 does not contribute. The
primordial (22) and essential identity element G73 in bacterial and
eukaryal aspartylation systems (26) is present in the three domains of life
including organelles, with the sole exception of mitochondria from
mammals (41). No additional identity element has been found (within
the limit of the obvious candidates explored herein). It is of particular
interest to notice that the mt aspartate identity set departs not only in a
general manner from other aspartylation systems but also more specif-
ically from the E. coli system despite the high sequence similarity of
E. coli and Hs mt-AspRSs. Base pair 2–71 is not important and, within
the anticodon triplet, the strength of the determinants is distinct: G34
U35 C36 in E. coli and G34 U35  C36 in Hs mitochondria.
Finally, the mt enzyme is not sensitive to structural features in the cor-
ner of the tRNA three-dimensional structure because it aminoacylates
as well a Hs mt-tRNAAsp transcript transplanted with canonical D- and
T-loops like E. coli tRNAAsp of classical structure (12).
Non-conservation of major identity elements in aminoacylation sys-
tems of a same specificity has been reported previously, especially non-
conservation of the discriminator base in different organisms (3). For
example, specific prolylation requires A73 and C1-G72 in E. coli
whereas these positions are not involved in proline identity inHs cytosol
(42). U73 is a determinant for E. coli GlyRS whereas GlyRSs from
archaea and eukaryotes recognize A73 (43). In these cases, variations in
identity elements exist when comparing a bacterial system and either an
archaeal or an eukaryal system, where synthetases are rather distinct. In
the aspartate case, two synthetases of the same evolutionary origin obey
different aminoacylation rules. E. coli AspRS and the bacterial type Hs
mt-AspRS are very similar, but one requires strong identity elements at
both ends of its substrate (the anticodon and the discriminator base)
whereas the other relies only on the anticodon. A similar situation has
been reported inArabidopsis thaliana for aminor identity element with
a prokaryotic-type mt-GlyRS not sensitive to residue 73, whereas E. coli
enzyme is dependent on U73 (44).
Understanding Non-discrimination of Residue 73 for Recognition by
mt-AspRS—The striking unimportance of residue 73 for Hs mt-AspRS,
as opposed to its importance for bacterial or eukaryal AspRSs, has been
tackled. Because of the very high similarity of theHsmt enzymewith the
E. coli AspRS, functional differences have been searched between these
two enzymes. First, their cross-aminoacylation properties have been
evaluated. Mt-AspRS was found to have a broad charging spectrum
including, in addition to its cognate tRNA, tRNAAsp from E. coli, T.
thermophilus, and S. cerevisiae tRNAAsp (supplemental Fig. S2A), which
all possess the full set of aspartate identity elements and classical struc-
tural features. Of particular interest is the tRNA from T. thermophilus,
which is especially GC rich and thus of opposite thermodynamic stabil-
ity to the cognate mt-tRNA substrate. In contrast, E. coliAspRS amino-
acylates tRNAAsp from Hs cytoplasm (not shown) but not from yeast
(45) nor does it aspartylate the Hsmt-tRNAAsp (supplemental Fig. S2B).
Rejection of the mt-tRNA by the E. coli enzyme may simply be due to
the absence of the major identity element G73. However, E. coli AspRS
does not recognize a variant mt-tRNAAsp with G73 (and thus with the
full set of major identity elements). The charging level is1% (supple-
mental Fig. S2B). These data are in favor of (i) non-adapted structural
scaffold of themt-tRNA for the E. coli enzyme, (ii) and/or missing iden-
tity elements, (iii) and/or the presence of antideterminants in Hs mt-
tRNAAsp hindering productive aspartylation. In other words, two syn-
thetases of the same evolutionary origin obey different aminoacylation
rules.
Sequence comparison of mt- and E. coli AspRSs was then used to
identify structural differences potentially responsible for non-discrimi-
nation of position 73 by mt-AspRS (Fig. 3A). Arginine (Arg-222) and
aspartate (Asp-220) in motif 2 within the catalytic domain are con-
served in all knownbacterial AspRSs and establish specific contactswith
G73.Whereas Arg-222 is conserved inmt-AspRS (Arg-271), Asp-220 is
replaced by a glycine (Gly-269), designating this residue as a potential
candidate contributing for non-discrimination of G73. Based on these
observations, Gly-269 was replaced by aspartate 269, and aspartylation
capacity of mt-AspRS/G269D was tested in the presence of WT mt-
tRNAAsp and the three variants of position 73 (C73, G73, and U73).
Residues of E. coli AspRS specifically contacting G73 are displayed in
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Fig. 3B on the crystallographic structure of the E. coli AspRS-tRNAAsp
complex (46). Activity of mt-AspRS/G269D, as estimated by maximal
rate measurements, is 10-fold decreased for WT mt-tRNAAsp com-
pared with the wild-type enzyme. In contrast to WT mt-AspRS, which
recognizes quite similarly the four substrates, mt-AspRS/G269D is
more sensitive to variant G73 (Fig. 3C). A detailed kinetic analysis like-
wise yielded a kcat value of the G73 variant3-fold increased compared
with WT mt-tRNAAsp but showed also a Km increase (Table 1) leading
to an overall comparable aminoacylation efficiency of WT and variant
G73 by mt-AspRS/G269D. The presence of Gly-269 in WT mt-AspRS
likely reduces the number of direct contacts (H-bonds) with base 73 and
thus may relax stringency within the protein region involved in mt-
tRNAAsp 3-end recognition. However, the moderate kinetic effects
observed for the single mutation on residue 269 suggest that other
structural features, still to be discovered, contribute as well to the unim-
portance of residue 73 in aspartylation identity of human mt-tRNAAsp.
In support of this viewwe note that specificity alterations or recognition
switches reported for non-mt aaRSs requiredmutation of several amino
acids close to tRNA identity residues, either in the anticodon (e.g. Refs.
47–49) or, like here, in the accepting stem (e.g. Refs. 50, 51).
Mt-AspRS Adaptation to mt-tRNA Rapid Evolution—Mitochondria
originate from engulfment of bacteria by primitive eukaryotes with pro-
gressive transfer of endosymbiont genes to the nuclear genome and
concomitant loss of other genes (10, 52). As a result, mammalian mt
genomes were reduced to a set of genes coding for only 13 proteins, 2
rRNAs, and 22 tRNAs. These genomes are subjected to a high muta-
tional rate because of the combination of oxidative environment and lim-
ited DNA repair activity. Accordingly, mammalian mt-tRNA acquired a
characteristic sequence degeneracy (53, 54) leading to strong polymor-
phism (55) and pathology-related mutations (56–58). In addition, the
biased nucleotide composition of themt genome (59) (highA/U/C con-
tent) favors what could be called a structural polymorphism, i.e. less
stable two-dimensional and more flexible three-dimensional structures
of mt-tRNAs compared with classical tRNAs.
Mammalian mt-aaRSs are nuclear encoded and sustain a low muta-
tional rate. Their genes originate either from a transfer from the original
endosymbiont or from duplication of the initial nuclear gene coding for
the cytosolic synthetase of the host (13). A limited number of mutations
along the tRNA-interacting surface are probably sufficient to enable
mt-AspRS to bemore tolerant of sequence and conformation variations
than the E. coli enzyme. This is first illustrated by the capacity of mt-
AspRS to charge a broad population of heterologous tRNAs, whereas
the E. coli ortholog cannot recognize mt-tRNAs. Second, the low sensi-
tivity to the discriminator base is an indication that the tRNA identity
rules have been relaxed. In conclusion, evolution of the aspartate system
in the mt context has consisted of a reduction in the number of identity
elements and extension in tolerance to structural fluctuations.
WhyaRestricted Identity Set CanBe Sufficient inMitochondria—The
mt translational machinery synthesizes only 13 proteins, all subunits of
the respiratory chain complexes and thus involved in energy synthesis.
Restriction of the aspartate aminoacylation identity set to the anticodon
loop raises questions about its sufficiency to guarantee specific amino-
acylation in the organelle. There are only 22 tRNAs inmammalianmito-
chondria; some share one or two nucleotides with tRNAAsp anticodon
triplet (tRNAGlu with the strongest aspartate elements U35 and C36;
tRNAHis, tRNAAsn, tRNATyr with G34 and U35; and tRNALys, tRNAVal,
and tRNAGln with U35, C36, andU35) andwould thus be candidates for
mischarging by AspRS. However, attempts to aminoacylate in vitro
transcribed Hs mt-tRNATyr were not successful (not shown), although
this tRNA is fully aminoacylated by its cognate mt-TyrRS. Further, a
variant mt-tRNATyr containing a complete GUC aspartate anticodon
triplet does not become a substrate forAspRS. This restrictedmischarg-
ing of mt-tRNAs by AspRS strongly suggests the presence of antideter-
minants within these tRNAs and/or limitations in their conformational
adaptation required for non-cognate catalysis.
Only limited data are available on tRNA identity inmammalianmito-
chondria (32). However, it has been postulated that mt-tRNAs contain
fewer sequence-specific recognition elements in addition to their anti-
codons because individual mt-tRNAs are so distinguishable that intri-
cate recognition mechanisms seem unnecessary (11). This view is now
experimentally validated for a few systems. In addition to the aspartate
system, Hs bacterial-type mt-TyrRS does not discriminate base pair
1–72 although it is a strong identity element for E. coli TyrRS (60), and
bovine mt-SerRS does not require the variable domain but rather the
T-loop (especially A58) and nucleotides replacing the D-loop (61, 62).
Such restricted identity sets in mt-tRNAs may be correlated with the
lower catalytic efficiency of mt aminoacylation systems compared with
bacterial or eukaryal cytosolic systems (9).
Accuracy of mitochondrial protein synthesis remains an open ques-
tion. In a systematic investigation of bovine mt-tRNAs, it was shown
FIGURE 3. Targeting relaxed specificity of human mt-AspRS. A, sequence alignment
ofmotif 2of selectedAspRSs (NCBI accessionnumbers:Hsmt, translated fromAL833633;
M. musculus mt, NP_76623; E. coli, P21889; T. thermophilus, P36419; S. cerevisiae mt,
NP_015221; S. cerevisiae, P04802). Black and gray boxes show strictly identical and similar
residues, respectively. Arrowheads locate E. coli residues Asp-220 and Arg-222 specifi-
cally contacting base G73 in the crystallographic structure of the complex (46). B, zoom-
ing into the binding pocket of residue G73 in the structure of E. coli complex (left, WT
sequence, numbering according to E. coli AspRS; right, mutated sequence with replace-
ment of Asp-269 into Gly-269, numbering according tomt-AspRS). C, aminoacylation by
WT (left) and mutated (right) mt-AspRSs of in vitro transcribed WT and variant
mt-tRNAAsp. Reactions were performed under saturating tRNA concentrations (8 M
transcripts, 50 nM enzyme).
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that mt-SerRSmarkedly misaminoacylates several of them (63). Several
reports bring strong support to the fact that, contrary to other syntheta-
ses, mt-ProRS (64), mt-LeuRS (65), and mt-PheRS (66) have lost their
editing activity, i.e. the proofreading step for errors in amino acid
selection during the aminoacylation process. Interestingly, mt-LeuRS
ensures fidelity thanks to a higher specificity for its cognate amino acid
restricting the error rate of mischarging (65). In the case of mt-PheRS, it
remains open whether quality control in mitochondria is focused on
another step than editing (for example, via a more efficient protein
degradation machinery) or whether translation in mitochondria is
inherently less accurate (66).
Evolution and Mitochondria—Evolution of aminoacylation systems
has been discussed in several instances (67–69). Primordial systems
were likely composed of minihelices (“ur” acceptor stems) recognized
by aaRS ancestors restricted to their catalytic core (70). An early “oper-
ational RNA code” typically formed of the three first tRNA acceptor
stem base pairs and of residue N73, fairly named “discriminator base”,
may have preceded emergence of the genetic code (71). Subsequent
evolution of aminoacylation systems was driven by insertion of addi-
tional tRNAdomains and aaRSmodules with concomitant expansion of
tRNA identity sets, now composed of conserved major elements and
idiosyncratic species-specific minor features. The present study on an
mt aspartylation system reveals loss of a strongly conservedmajor iden-
tity element, G73. This restriction suggests a reverse evolution of this
aminoacylation system in regard to its bacterial-type ancestor. Residue
G73 was likely the primordial aspartate identity element because spe-
cific aminoacylation of minimalist tRNA substrates is possible (22). Its
loss as a major aspartate element from bacteria to bacteria-like (Hs mt)
systems illustrates a rupture of the operational RNA code within the
aforementioned evolutionary-related biological systems. This situation
was likely driven by the high mutational rate of the mt genome but also
by a less stringent need of intricate identity rules due to a simplified
tRNA world in mitochondria. The synthetase has adapted to allow for
preservation of complementarity with its substrate by mutation of at
least a critical aspartate residue into a glycine. One may question
whether, because of the high tRNA degeneracy, reverse evolution of mt
aminoacylation systems is a general trend in mammals?
Acknowledgments—J. Rudinger-Thirion, L. Bonnefond, and M. Frugier are
acknowledged for helpful discussions, A. Cle´net for technical assistance, andH.
Becker, L. Bonnefond, G. Eriani, D. Kern, and J. Rudinger-Thirion for gifts of
material.
REFERENCES
1. Giege´, R., Sissler, M., and Florentz, C. (1998) Nucleic Acids Res. 26, 5017–5035
2. Beuning, P. J., and Musier-Forsyth, K. (1999) Biopolymers 52, 1–28
3. Giege´, R., and Frugier, M. (2003) in Translation Mechanisms (Lapointe, J., and
Brakier-Gringas, L., eds) pp. 1–24, Landes Sciences, Georgetown, TX
4. Saks, M. E., and Sampson, J. R. (1996) EMBO J. 15, 2843–2849
5. Frugier,M., Helm,M., Felden, B., Giege´, R., and Florentz, C. (1998) J. Biol. Chem. 273,
11605–11610
6. Giege´, R., Frugier, M., and Rudinger, J. (1998) Curr. Opin. Struct. Biol. 8, 286–293
7. Hauenstein, S., Zhang, C.M.,Hou, Y.M., andPerona, J. J. (2004)Nat. Struct.Mol. Biol.
11, 1134–1141
8. Helm, M., Brule´, H., Friede, D., Giege´, R., Pu¨tz, J., and Florentz, C. (2000) RNA 6,
1356–1379
9. Florentz, C., Sohm, B., Tryoen-To´th, P., Pu¨tz, J., and Sissler, M. (2003) Cell. Mol. Life
Sci. 60, 1356–1375
10. Margulis, L. (1981) Symbiosis in Cell Evolution, W. H. Freeman, San Francisco
11. Kumazawa, Y., Himeno, H., Miura, K.-I., and Watanabe, K. (1991) J. Biochem. 109,
421–427
12. Bonnefond, L., Fender, A., Rudinger-Thirion, J., Giege´, R., Florentz, C., and Sissler,M.
(2005) Biochemistry 44, 4805–4816
13. Sissler,M., Pu¨tz, J., Fasiolo, F., and Florentz, C. (2005) inAminoacyl-tRNASynthetases
(Ibba, M., Francklyn, C., and Cusack, S. eds) pp. 271–284, Landes Biosciences, Geor-
getown, TX
14. Eriani, G., Delarue, M., Poch, O., Gangloff, J., and Moras, D. (1990) Nature 347,
203–206
15. Cusack, S., Berthet-Colominas, C., Ha¨rtlein, M., Nassar, N., and Leberman, R. (1990)
Nature 347, 249–255
16. Small, I. D., Wintz, H., Akashi, K., and Mireau, H. (1998) Plant Mol. Biol. 38,
265–277
17. Ducheˆne, A. M., Giritch, A., Hoffmann, B., Cognat, V., Lancelin, D., Peeters, N. M.,
Zaepfel, M., Marechal-Drouard, L., and Small, I. D. (2005) Proc. Natl. Acad. Sci.
U. S. A. 102, 16484–16489
18. Hasegawa, T., Himeno, H., Ishikura, H., and Shimizu, M. (1989) Biochem. Biophys.
Res. Comm. 163, 1534–1538
19. Nameki, N., Tamura, K., Himeno, H., Asahara, H., Hasegawa, T., and Shimuzu, M.
(1992) Biochem. Biophys. Res. Comm. 189, 856–862
20. Pu¨tz, J., Puglisi, J. D., Florentz, C., and Giege´, R. (1991) Science 252, 1696–1699
21. Frugier, M., So¨ll, D., Giege´, R., and Florentz, C. (1994) Biochemistry 33, 9912–9921
22. Frugier, M., Florentz, C., and Giege´, R. (1994) EMBO J. 13, 2218–2226
23. Ryckelynck, M., Giege´, R., and Frugier, M. (2003) J. Biol. Chem. 278, 9683–9690
24. Becker, H. D., Giege´, R., and Kern, D. (1996) Biochemistry 35, 7447–7458
25. Giege´, R., Puglisi, J. D., and Florentz, C. (1993) Prog. Nucleic Acids Res. Mol. Biol. 45,
129–206
26. Giege´, R., Florentz, C., Kern, D., Gangloff, J., Eriani, G., and Moras, D. (1996) Bio-
chimie (Paris) 78, 605–623
27. Giege´, R., and Rees, B. (2005) in Aminoacyl-tRNA Synthetases, (Ibba, M., Francklyn,
C., and Cusack, S., eds) pp. 210–226, Landes Bioscience, Georgetown, TX
28. Perret, V., Garcia, A., Puglisi, J. D., Grosjean, H., Ebel, J.-P., Florentz, C., and Giege´, R.
(1990) Biochimie (Paris) 72, 735–744
29. Fechter, P., Rudinger, J., Giege´, R., and The´obald-Dietrich, A. (1998) FEBS Lett. 436,
99–103
30. Bonnet, J., and Ebel, J.-P. (1972) Eur. J. Biochem. 31, 335–344
31. Schulman, L. H., and Pelka, H. (1988) Science 242, 765–768
32. Levinger, L., Mo¨rl, M., and Florentz, C. (2004) Nucleic Acids Res. 32, 5430–5441
33. Perret, V., Garcia, A., Grosjean, H., Ebel, J.-P., Florentz, C., and Giege´, R. (1990)
Nature 344, 787–789
34. Sohm, B., Frugier, M., Brule´, H., Olszak, K., Przykorska, A., and Florentz, C. (2003) J.
Mol. Biol. 328, 995–1010
35. Sissler, M., Helm, M., Frugier, M., Giege´, R., and Florentz, C. (2004) RNA 10,
841–853
36. Bullard, J., Cai, Y.-C., Demeler, B., and Spremulli, L. (1999) J. Mol. Biol. 288, 567–577
37. Bullard, J., Cai, Y.-C., and Spremulli, L. (2000) Biochim. Biophys. Acta 1490, 245–258
38. Kelley, S., Steinberg, S., and Schimmel, P. (2000) Nat. Struct. Biol. 7, 862–865
39. Jørgensen, R., Søgarrd,M.M., Rossing, A. B.,Martensen, P.M., and Justesen, J. (2000)
J. Biol. Chem. 275, 16820–16826
40. Spencer, A., Heck, A., Takeuchi, N.,Watanabe, K., and Spremulli, L. (2004) Biochem-
istry 43, 9743–9754
41. Sprinzl, M., and Vassilenko, K. S. (2005) Nucleic Acids Res. 33, D139–D140
42. Stehlin, C., Burke, B., Yang, F., Liu, H., Shiba, K., and Musier-Forsyth, K. (1998)
Biochemistry 37, 8605–8613
43. Shiba, K., Motegi, H., and Schimmel, P. (1997) Trends Biochem. Sci. 22, 453–457
44. Ducheˆne, A.M., Peeters, N., Dietrich, A., Cosset, A., Small, I. D., andWintz, H. (2001)
J. Biol. Chem. 276, 15275–15283
45. Moulinier, L., Eiler, S., Eriani, G., Gangloff, J., Thierry, J.-C., Gabriel, K., McClain,
W. H., and Moras, D. (2001) EMBO J. 20, 5290–5301
46. Eiler, S., Dock-Bregeon, A. C., Moulinier, L., Thierry, J.-C., and Moras, D. (1999)
EMBO J. 18, 6532–6541
47. Schmitt, E., Meinnel, T., Panvert, M., Mechulam, Y., and Blanquet, S. (1993) J. Mol.
Biol. 233, 615–628
48. Auld, D. S., and Schimmel, P. (1995) Science 267, 1994–1996
49. Auld, D. S., and Schimmel, P. (1996) EMBO J. 15, 1142–1148
50. Wakasugi, K., Quinn, C. L., Tao, N., and Schimmel, P. (1998) EMBO J. 17, 297–305
51. Connolly, S. A., Rosen,A. E.,Musier-Forsyth, K., and Francklyn, C. S. (2004)Biochem-
istry 43, 962–969
52. Gray, M. W., Burger, G., and Lang, B. F. (2001) Genome Biol. 2, 1018.1–1018.5
53. Lynch, M. (1996)Mol. Biol. Evol. 13, 209–220
54. Galtier, N., Enard, D., Radondy, Y., Bazin, E., and Belkhir, K. (2006) Genome Res. 16,
215–222
55. Ingman, M., Kaessmann, H., Pa¨a¨bo, S., and Gyllenstein, U. (2000) Nature 408,
708–713
56. Schon, E. A., Bonilla, E., and DiMauro, S. (1997) J. Bioenerg. Biomemb. 29, 131–149
57. Wallace, D. C. (1999) Science 283, 1482–1488
58. McFarland, R., Elson, J. L., Taylor, R. W., Howell, N., and Turnbull, D. M. (2004)
Trends Genet. 20, 591–596
59. Anderson, S., Bankier, A. T., Barrel, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin,
J., Eperon, J. C., Nierlich, D. P., Roe, B. A., Sanger, F., Schreier, P. H., Smith, A. J. H.,
Aspartate Identity in HumanMitochondria
JUNE 9, 2006•VOLUME 281•NUMBER 23 JOURNAL OF BIOLOGICAL CHEMISTRY 15985
Staden, R., and Young, I. G. (1981) Nature 290, 457–465
60. Bonnefond, L., Frugier, M., Giege´, R., and Rudinger-Thirion, J. (2005) RNA 11,
558–562
61. Ueda, T., Yotsumoto, Y., Ikeda, K., and Watanabe, K. (1992) Nucleic Acids Res. 20,
2217–2222
62. Chimnaronk, S., Gravers Jeppesen, M., Suzuki, T., Nyborg, J., and Watanabe, K.
(2005) EMBO J. 24, 3369–3379
63. Shimada, N., Matsuzaki, K., Suzuki, T., Suzuki, T., and Watanabe, K. (2002) Nucleic
Acids Res. 2, (suppl.) 79–80
64. Beuning, P. J., and Musier-Forsyth, K. (2001) J. Biol. Chem. 276, 30779–30785
65. Lue, S. W., and Kelley, S. O. (2005) Biochemistry 44, 3010–3016
66. Roy, H., Ling, J., Alfonzo, J., and Ibba, M. (2005) J. Biol. Chem. 280, 38186–38192
67. Woese, C. R., Olsen, G. J., Ibba, M., and So¨ll, D. (2000)Microbiol. Mol. Biol. Rev. 64,
202–236
68. Ribas de Pouplana, L., and Schimmel, P. (2000) Cell Mol. Life Sci. 57, 865–670
69. Chihade, J.W., Brown, J. R., Schimmel, P., and Ribas de Pouplana, L. (2000) Proc. Natl.
Acad. Sci. U. S. A. 97, 12153–12157
70. Schimmel, P., Giege´, R., Moras, D., and Yokoyama, S. (1993) Proc. Natl. Acad. Sci.
U. S. A. 90, 8763–8768
71. Schimmel, P. (1995) J. Mol. Evol. 40, 531–536
Aspartate Identity in HumanMitochondria
15986 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 281•NUMBER 23•JUNE 9, 2006
